483
Cell Therapeutics IncFDA 483 - Cell Therapeutics Inc - November 18, 2009
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Cell Therapeutics Inc in Seattle, WA, revealed a significant lapse in regulatory reporting for clinical trials. The firm failed to notify the FDA about the termination, for cause, of an investigator's participation in a clinical study. This indicates a deficiency in the firm's oversight and compliance with clinical investigation regulations.
Open in Dashboard
ID · 2248d087-6b31-4b4c-a7d3-d6d991c8d84e